These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7510475)

  • 21. Identification of a major hepatitis B core antigen (HBcAg) determinant by using synthetic peptides and monoclonal antibodies.
    Colucci G; Beazer Y; Cantaluppi C; Tackney C
    J Immunol; 1988 Dec; 141(12):4376-80. PubMed ID: 2461991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Common linear B-cell epitopes in human hepatitis B virus core protein and woodchuck hepatitis virus core protein].
    Zhang ZH; Wang R; Tian YJ; Li L; Xia JB; Gong JS; Lu MJ; Gong FL; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):605-8. PubMed ID: 17711632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-region.
    Street M; Herd K; Londono P; Doan T; Dougan G; Kast WM; Tindle RW
    Arch Virol; 1999; 144(7):1323-43. PubMed ID: 10481740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization of immunodominant epitopes within the "a" determinant of hepatitis B surface antigen using monoclonal antibodies.
    Golsaz-Shirazi F; Mohammadi H; Amiri MM; Khoshnoodi J; Kardar GA; Jeddi-Tehrani M; Shokri F
    Arch Virol; 2016 Oct; 161(10):2765-72. PubMed ID: 27439498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with recombinant woodchuck hepatitis virus nucleocapsid antigen or hepatitis B virus nucleocapsid antigen protects woodchucks from woodchuck hepatitis virus infection.
    Schödel F; Neckermann G; Peterson D; Fuchs K; Fuller S; Will H; Roggendorf M
    Vaccine; 1993; 11(6):624-8. PubMed ID: 8322485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens.
    Shahhosseini S; Das D; Qiu X; Feldmann H; Jones SM; Suresh MR
    J Virol Methods; 2007 Jul; 143(1):29-37. PubMed ID: 17368819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of human monoclonal antibodies directed against hepatitis B surface antigen.
    Ehrlich PH; Moustafa ZA; Justice JC; Harfeldt KE; Kelley RL; Ostberg L
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):2-7. PubMed ID: 1374272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies against different epitopes of nonstructural protein sigmaNS of avian reovirus S1133.
    Hou HS; Su YP; Shieh HK; Lee LH
    Virology; 2001 Mar; 282(1):168-75. PubMed ID: 11259199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg).
    Golsaz-Shirazi F; Amiri MM; Farid S; Bahadori M; Bohne F; Altstetter S; Wolff L; Kazemi T; Khoshnoodi J; Hojjat-Farsangi M; Chudy M; Jeddi-Tehrani M; Protzer U; Shokri F
    Antiviral Res; 2017 Aug; 144():153-163. PubMed ID: 28641998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibodies raised to purified woodchuck hepatitis virus core antigen particles demonstrate X antigen reactivity.
    Feitelson MA; Clayton MM; Phimister B
    Virology; 1990 Jul; 177(1):357-66. PubMed ID: 2353460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination.
    Schödel F; Peterson D; Hughes J; Milich DR
    Vaccine; 1993; 11(2):143-8. PubMed ID: 7679864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of the immunogenicity and immunoenhancing effects of two hepatitis B core antigen variants in mice by nasal administration.
    Lobaina Y; Palenzuela D; García D; Rodríguez D; Pichardo D; Muzio V; Aguilar JC
    Vaccine; 2006 Apr; 24 Suppl 2():S2-58-9. PubMed ID: 16823928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunochemical structure of the carboxy-terminal part of hepatitis B e antigen: identification of internal and surface-exposed sequences.
    Sällberg M; Pushko P; Berzinsh I; Bichko V; Sillekens P; Noah M; Pumpens P; Grens E; Wahren B; Magnius LO
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1335-40. PubMed ID: 7687649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
    Orvell C; Norrby E; Mufson MA
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies.
    Zanella I; Verardi R; Negrini R; Osio L; Albertini A; Ghielmi S
    Year Immunol; 1993; 7():213-9. PubMed ID: 8396821
    [No Abstract]   [Full Text] [Related]  

  • 37. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology].
    Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential antigen-processing pathways of the hepatitis B virus e and core proteins.
    Diepolder HM; Ries G; Jung MC; Schlicht HJ; Gerlach JT; Gr ner N; Caselmann WH; Pape GR
    Gastroenterology; 1999 Mar; 116(3):650-7. PubMed ID: 10029624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles.
    Simanavicius M; Tamosiunas PL; Petraityte-Burneikiene R; Johne R; Ulrich RG; Zvirbliene A; Kucinskaite-Kodze I
    Appl Microbiol Biotechnol; 2018 Jan; 102(1):185-198. PubMed ID: 29143081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B core antigen based novel vaccine against porcine epidemic diarrhea virus.
    Gillam F; Zhang J; Zhang C
    J Virol Methods; 2018 Mar; 253():61-69. PubMed ID: 29129402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.